Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Jun;69(6):1157–1159. doi: 10.1038/bjc.1994.227

Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C.

J F Tsai 1, W Y Chang 1, J E Jeng 1, M S Ho 1, Z Y Lin 1, J H Tsai 1
PMCID: PMC1969433  PMID: 7515263

Abstract

Antibody to hepatitis C virus (anti-HCV) was found to be an independent risk factor for hepatocellular carcinoma and raised serum alpha-fetoprotein (AFP) level. In addition, the frequency of raised AFP in patients with anti-HCV was higher than in those without (91.5% vs 65.2%, P = 0.0001).

Full text

PDF
1157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen D. S., Sung J. L. Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in nonmalignant diseases of the liver. Cancer. 1979 Sep;44(3):984–992. doi: 10.1002/1097-0142(197909)44:3<984::aid-cncr2820440328>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  2. Eckhardt S., Badellino F., Murphy G. P. UICC meeting on breast-cancer screening in pre-menopausal women in developed countries. Geneva, 29 September-1 October 1993. Int J Cancer. 1994 Jan 2;56(1):1–5. doi: 10.1002/ijc.2910560102. [DOI] [PubMed] [Google Scholar]
  3. Jeng J. E., Tsai J. F. Hepatitis C virus antibody in hepatocellular carcinoma in Taiwan. J Med Virol. 1991 May;34(1):74–77. doi: 10.1002/jmv.1890340113. [DOI] [PubMed] [Google Scholar]
  4. Lee H. S., Chung Y. H., Kim C. Y. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma. Hepatology. 1991 Jul;14(1):68–72. doi: 10.1002/hep.1840140112. [DOI] [PubMed] [Google Scholar]
  5. Sheu J. C., Huang G. T., Shih L. N., Lee W. C., Chou H. C., Wang J. T., Lee P. H., Lai M. Y., Wang C. Y., Yang P. M. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology. 1992 Oct;103(4):1322–1327. doi: 10.1016/0016-5085(92)91523-7. [DOI] [PubMed] [Google Scholar]
  6. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Lin Z. Y., Tsai J. H. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver. 1994 Apr;14(2):98–102. doi: 10.1111/j.1600-0676.1994.tb00055.x. [DOI] [PubMed] [Google Scholar]
  7. Tsai J. F., Chang W. Y., Jeng J. E., Ho M. S., Wang L. Y., Hsieh M. Y., Chen S. C., Chuang W. L., Lin Z. Y., Tsai J. H. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol. 1993 Dec;41(4):296–300. doi: 10.1002/jmv.1890410407. [DOI] [PubMed] [Google Scholar]
  8. Tsai J. F., Jeng J. E., Chang W. Y., Lin Z. Y., Tsai J. H. Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B. Scand J Gastroenterol. 1994 Jun;29(6):550–552. doi: 10.3109/00365529409092471. [DOI] [PubMed] [Google Scholar]
  9. Yano M., Yatsuhashi H., Inoue O., Inokuchi K., Koga M. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut. 1993;34(2 Suppl):S13–S16. doi: 10.1136/gut.34.2_suppl.s13. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES